ESCIPION PEDROZA

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism METAIRIE, LA NPI 1306807771

General Payments — all program years on this page

$1,728.95

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 97
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $394.54 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $394.5421

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $218.8314
2019 $239.2514
2020 $57.043
2022 $431.0723
2023 $388.2222
2024 $394.5421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087875149 BETA BIONICS, INC. $18.16 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087875607 BETA BIONICS, INC. $14.38 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089087476 Ascensia Diabetes Care Us Inc. $16.23 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093959351 Alexion Pharmaceuticals, Inc. $21.64 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111673951 Amgen Inc. $16.15 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117153525 Medtronic, Inc. $20.49 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117153527 Medtronic, Inc. $24.88 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117956964 Boehringer Ingelheim Pharmaceuticals, Inc. $15.72 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126635484 Acella Pharmaceuticals, LLC $17.82 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133850016 Ascendis Pharma Inc $17.25 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134969533 Lilly USA, LLC $19.10 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136167512 Lilly USA, LLC $19.28 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136170283 Lilly USA, LLC $15.75 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136173138 Lilly USA, LLC $16.16 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139305668 Astellas Pharma US Inc $16.38 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142984572 IBSA Pharma Inc. $24.53 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144594270 Xeris Pharmaceuticals, Inc. $20.56 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144594272 Xeris Pharmaceuticals, Inc. $13.87 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146478724 Antares Pharma, Inc. $17.95 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153299487 Dexcom, Inc. $29.00 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153299489 Dexcom, Inc. $19.24 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.